Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1982-12-21
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0392-2936
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
127-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7347682-Ascitic Fluid,
pubmed-meshheading:7347682-Carcinoma,
pubmed-meshheading:7347682-Female,
pubmed-meshheading:7347682-Fibrin Fibrinogen Degradation Products,
pubmed-meshheading:7347682-Humans,
pubmed-meshheading:7347682-Liver Cirrhosis,
pubmed-meshheading:7347682-Ovarian Neoplasms
|
pubmed:year |
1981
|
pubmed:articleTitle |
Fibrinogen degradation products (F.D.P.) in ascitic fluid of patients affected by ovarian cancer.
|
pubmed:publicationType |
Journal Article
|